News Releases

Anixa Biosciences Announces Collaboration with Urology Centers of Alabama on Cchek™ Prostate Cancer Study

November 22, 2019

Anixa Biosciences Announces Collaboration with Idaho Urologic Institute on Cchek™ Prostate Cancer Study

November 20, 2019

Anixa Biosciences Announces Presentation at Cell Symposia: Hallmarks of Cancer

November 7, 2019

Anixa Biosciences Announces Patent Issued for its Breast Cancer Vaccine

November 5, 2019

Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board

October 28, 2019

Anixa Biosciences Announces Collaboration with Urology San Antonio on Cchek™ Prostate Cancer Study

October 25, 2019

Anixa Biosciences Announces Abstract Accepted for Presentation at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2019)

October 22, 2019

Anixa Biosciences Appoints Dr. Thomas Schlumpberger as Executive Vice President of Diagnostics to Head Liquid Biopsy Development and Commercialization Efforts

October 15, 2019

Anixa Biosciences Names Cancer Vaccine Pioneer Dr. Ian H. Frazer to Scientific Advisory Board

October 10, 2019

Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchek™ Prostate Cancer Study

September 23, 2019

« Previous
1
2
3
4
5
6
7
8
9
10
...18
Next »

Latest News & Events

May 26, 2021

Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Cleveland Clinic

Read More...

May 20, 2021

Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from US FDA for CAR-T IND Application

Read More...

May 7, 2021

OntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie

Read More...